This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Fundacion Centro Nacional De Investigaciones Oncologicas Carlos III. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Luis Ignacio Toledo Lázaro: Innovator in Cancer Treatment
Introduction
Luis Ignacio Toledo Lázaro is a prominent inventor based in Zaragoza, Spain. He has made significant contributions to the field of oncology through his innovative research and development of chemical entities that hold promise in cancer treatment. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Latest Patents
Toledo Lázaro holds a patent for chemical entities that are inhibitors of ATR, which are potentially useful in the treatment of cancer. The patent details compounds of formula (I), wherein R, R', and m have specific meanings as described in the documentation. Additionally, the patent encompasses pharmaceutically acceptable salts, solvates, and stereoisomers of these compounds. The invention also includes pharmaceutical compositions of the chemical entities, combination products, and methods of treatment utilizing these compositions.
Career Highlights
Toledo Lázaro is affiliated with the Fundación Centro Nacional de Investigaciones Oncológicas Carlos III, where he conducts his research. His work has been instrumental in the development of new therapeutic agents aimed at combating cancer. His dedication to research and innovation has positioned him as a key figure in the field of oncology.
Collaborations
Throughout his career, Toledo Lázaro has collaborated with notable colleagues, including Joaquín Pastor Fernández and Oscar Fernández-Capetillo Ruiz. These collaborations have further enriched his research and contributed to the advancement of cancer treatment methodologies.
Conclusion
Luis Ignacio Toledo Lázaro exemplifies the spirit of innovation in the medical field, particularly in cancer research. His contributions through patents and collaborations highlight the importance of scientific advancement in improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile